Nassau 2019 CFO keeps its bond and liquidity ratings as Fitch removes its criteria observation, reflecting sustained ...

What happened? A number of stocks fell in the morning session as Democratic victories in the U.S. midterm elections continued ...

What happened? A number of stocks fell in the morning session after Datadog projected fourth-quarter revenue that implied flat sequential growth, triggering ...

Bitcoin’s weakness and broader market uncertainty continue to challenge altcoins, making a sustained recovery important for ...

Tesla shares faced volatility amid U.S. midterm election outcomes and policy shift concerns.Shanghai Gigafactory data showed ...

Palantir Technologies reported third-quarter revenue of $2.31 billion on Nov. 2, up 96% from a year earlier, and then handed ...

Crypto analyst Ali Martinez says XRP’s chart has tightened to a level last seen in August, but the setup does not say which ...

As of 05-Sep, Affle 3i Ltd's stock price is rising to 1,617.85, up 6.42%, driven by strong investor interest, significant gains over the past days, and positive financial performance. The company is ...

Objective: Lumateperone is an FDA-approved atypical antipsychotic to treat schizophrenia, bipolar I or II depression, and major depressive disorder (MDD). Post hoc analyses of a randomized, phase 3, ...

Palantir reports a strong Q3 and issues upbeat future guidance. But newly signed US commercial contracts climbed only 11%. Palantir stock is currently up some 6% versus the start of 2026.

AI-generated Xylem (XYL) stock analysis report, as of Oct 28, 2026. See XYL business overview, financial statement overview, technical analysis and price target.

A meta-analysis of nine randomized trials found that albumin resuscitation did not significantly reduce acute kidney injury ...